Ginsenoside Rg3

Details

Top
Internal ID ede00223-1d30-4412-baa3-c449053f701a
Taxonomy Lipids and lipid-like molecules > Prenol lipids > Terpene glycosides > Triterpene glycosides > Triterpene saponins
IUPAC Name (2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-17-[(2S)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
SMILES (Canonical) CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)C)O)C)O)C
SMILES (Isomeric) CC(=CCC[C@@](C)([C@H]1CC[C@@]2([C@@H]1[C@@H](C[C@H]3[C@]2(CC[C@@H]4[C@@]3(CC[C@@H](C4(C)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)C)C)O)C)O)C
InChI InChI=1S/C42H72O13/c1-21(2)10-9-14-42(8,51)22-11-16-41(7)29(22)23(45)18-27-39(5)15-13-28(38(3,4)26(39)12-17-40(27,41)6)54-37-35(33(49)31(47)25(20-44)53-37)55-36-34(50)32(48)30(46)24(19-43)52-36/h10,22-37,43-51H,9,11-20H2,1-8H3/t22-,23+,24+,25+,26-,27+,28-,29-,30+,31+,32-,33-,34+,35+,36-,37-,39-,40+,41+,42-/m0/s1
InChI Key RWXIFXNRCLMQCD-JBVRGBGGSA-N
Popularity 460 references in papers

Physical and Chemical Properties

Top
Molecular Formula C42H72O13
Molecular Weight 785.00 g/mol
Exact Mass 784.49729235 g/mol
Topological Polar Surface Area (TPSA) 219.00 Ų
XlogP 4.00
Atomic LogP (AlogP) 2.15
H-Bond Acceptor 13
H-Bond Donor 9
Rotatable Bonds 10

Synonyms

Top
14197-60-5
20(S)-Ginsenoside Rg3
(20S)-Propanaxadiol
20s-ginsenoside rg3
20S-propanaxadiol
(20S)-ginsenoside Rg3
S-Ginsenoside Rg3
20(S)-Ginsenoside-Rg3
20(S)-Propanaxidiol
CHEMBL398412
There are more than 10 synonyms. If you wish to see them all click here.

2D Structure

Top
2D Structure of Ginsenoside Rg3

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.6877 68.77%
Caco-2 - 0.8840 88.40%
Blood Brain Barrier - 0.5500 55.00%
Human oral bioavailability - 0.7714 77.14%
Subcellular localzation Mitochondria 0.7251 72.51%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.7934 79.34%
OATP1B3 inhibitior + 0.8189 81.89%
MATE1 inhibitior - 0.9800 98.00%
OCT2 inhibitior - 0.6000 60.00%
BSEP inhibitior - 0.4911 49.11%
P-glycoprotein inhibitior + 0.8063 80.63%
P-glycoprotein substrate - 0.9036 90.36%
CYP3A4 substrate + 0.7234 72.34%
CYP2C9 substrate - 0.7890 78.90%
CYP2D6 substrate - 0.8406 84.06%
CYP3A4 inhibition - 0.9502 95.02%
CYP2C9 inhibition - 0.8671 86.71%
CYP2C19 inhibition - 0.9036 90.36%
CYP2D6 inhibition - 0.9380 93.80%
CYP1A2 inhibition - 0.9057 90.57%
CYP2C8 inhibition + 0.6241 62.41%
CYP inhibitory promiscuity - 0.9413 94.13%
UGT catelyzed - 0.5000 50.00%
Carcinogenicity (binary) - 0.9900 99.00%
Carcinogenicity (trinary) Non-required 0.6474 64.74%
Eye corrosion - 0.9907 99.07%
Eye irritation - 0.9095 90.95%
Skin irritation - 0.5956 59.56%
Skin corrosion - 0.9488 94.88%
Ames mutagenesis - 0.7600 76.00%
Human Ether-a-go-go-Related Gene inhibition + 0.8437 84.37%
Micronuclear - 0.8800 88.00%
Hepatotoxicity - 0.5436 54.36%
skin sensitisation - 0.8991 89.91%
Respiratory toxicity + 0.5333 53.33%
Reproductive toxicity + 0.8889 88.89%
Mitochondrial toxicity - 0.5875 58.75%
Nephrotoxicity - 0.7155 71.55%
Acute Oral Toxicity (c) I 0.5677 56.77%
Estrogen receptor binding + 0.7418 74.18%
Androgen receptor binding + 0.7407 74.07%
Thyroid receptor binding - 0.5905 59.05%
Glucocorticoid receptor binding + 0.6369 63.69%
Aromatase binding + 0.6823 68.23%
PPAR gamma + 0.7336 73.36%
Honey bee toxicity - 0.5274 52.74%
Biodegradation - 0.6500 65.00%
Crustacea aquatic toxicity + 0.5300 53.00%
Fish aquatic toxicity + 0.9172 91.72%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 97.42% 91.11%
CHEMBL253 P34972 Cannabinoid CB2 receptor 96.48% 97.25%
CHEMBL6136 O60341 Lysine-specific histone demethylase 1 94.40% 95.58%
CHEMBL3137262 O60341 LSD1/CoREST complex 93.84% 97.09%
CHEMBL2996 Q05655 Protein kinase C delta 91.54% 97.79%
CHEMBL5608 Q16288 NT-3 growth factor receptor 91.15% 95.89%
CHEMBL241 Q14432 Phosphodiesterase 3A 90.23% 92.94%
CHEMBL226 P30542 Adenosine A1 receptor 89.68% 95.93%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 89.61% 96.09%
CHEMBL1293249 Q13887 Kruppel-like factor 5 89.39% 86.33%
CHEMBL5888 Q99558 Mitogen-activated protein kinase kinase kinase 14 88.22% 100.00%
CHEMBL1994 P08235 Mineralocorticoid receptor 88.16% 100.00%
CHEMBL3714130 P46095 G-protein coupled receptor 6 87.15% 97.36%
CHEMBL4187 Q99250 Sodium channel protein type II alpha subunit 84.88% 95.50%
CHEMBL1977 P11473 Vitamin D receptor 84.66% 99.43%
CHEMBL1937 Q92769 Histone deacetylase 2 84.51% 94.75%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 83.95% 94.45%
CHEMBL4478 Q00975 Voltage-gated N-type calcium channel alpha-1B subunit 83.85% 97.14%
CHEMBL2373 P21730 C5a anaphylatoxin chemotactic receptor 81.71% 92.62%
CHEMBL2274 Q9H228 Sphingosine 1-phosphate receptor Edg-8 81.71% 100.00%
CHEMBL2581 P07339 Cathepsin D 81.56% 98.95%
CHEMBL237 P41145 Kappa opioid receptor 81.36% 98.10%
CHEMBL4227 P25090 Lipoxin A4 receptor 80.85% 100.00%

Cross-Links

Top
PubChem 9918693
NPASS NPC120123
LOTUS LTS0174795
wikiData Q27077807